<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet href="/cr_weblayout/groups/cr_ta/@inm/@gen/documents/system/cr_rss_xsl.xsl" title="XSL_formatting" type="text/xsl"?>


		
			<rss xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
		<channel>
				<meta name="Author" content="Cancer Research UK"/>
				<meta name="Copyright" content="Copyright 2002 by Cancer Research UK"/>
				<meta name="DC.Type" scheme="DCMI" content="Document"/>
				<meta name="DC.Contributor" content="Cancer Research UK"/>
				<meta name="DC.Creator" content="Cancer Research UK"/>
				<meta name="DC.Publisher" content="Cancer Research UK"/>
				<meta name="DC.Rights" content="Cancer Research UK"/>
				<image>
					<url>http://www.cancerresearchuk.org/cr_weblayout/groups/cr_common/@inm/@gen/documents/image/cruk_logo_image.gif</url>
					<title>Cancer Research UK Podcasts</title>
					<link>http://www.cancerresearchuk.org/cancer-help/index.htm</link>
				</image>
				
		

		<title>Cancer Research UK - Science Update blog » Kidney cancer</title>
		<link>http://scienceblog.cancerresearchuk.org</link>
		<description>The latest news, views and opinions from Cancer Research UK</description>
		<language>en-US</language>
		

			<item>
				<title>Podcast: redefining breast cancer, tiny brain tumours, bowel cancer progress and more</title>
				<link>http://scienceblog.cancerresearchuk.org/2012/04/30/podcast-redefining-breast-cancer-tiny-brain-tumours-bowel-cancer-progress-and-more/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2012/04/30/podcast-redefining-breast-cancer-tiny-brain-tumours-bowel-cancer-progress-and-more/</guid>
				<pubDate>Mon, 30 Apr 2012 09:31:42 GMT</pubDate>
				<author>Kat Arney</author>
				<description><![CDATA[This month, we hear how a landmark study could revolutionise breast cancer treatment, and take a look at the growing evidence on aspirin and cancer. We also hear how obesity may be driving rises in kidney and womb cancer rates, &#8230; <a href="http://scienceblog.cancerresearchuk.org/2012/04/30/podcast-redefining-breast-cancer-tiny-brain-tumours-bowel-cancer-progress-and-more/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				<enclosure url="http://scienceblog.cancerresearchuk.org/wp-content/uploads/2012/04/064_cancer_research_uk_podcast_april_2012.mp3" length="15117919" type="audio/mpeg"/>
			</item>
			<item>
				<title>News digest – bowel cancer, kidney cancer, booze, boost for drug development, and more</title>
				<link>http://scienceblog.cancerresearchuk.org/2012/03/31/news-digest-bowel-cancer-brain-tumours-booze-boost-for-drug-development-and-more/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2012/03/31/news-digest-bowel-cancer-brain-tumours-booze-boost-for-drug-development-and-more/</guid>
				<pubDate>Sat, 31 Mar 2012 10:00:01 GMT</pubDate>
				<author>Oliver Childs</author>
				<description><![CDATA[Another week has flown by, and yet more interesting cancer research was in the news, both from our own scientists and from research groups around the world. We’ve summarised the big stories of the week below. Click on the links &#8230; <a href="http://scienceblog.cancerresearchuk.org/2012/03/31/news-digest-bowel-cancer-brain-tumours-booze-boost-for-drug-development-and-more/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				
			</item>
			<item>
				<title>Podcast: cancer genes, kids smoking, shunning sunbeds, and spotting the signs</title>
				<link>http://scienceblog.cancerresearchuk.org/2012/03/22/podcast-cancer-genes-kids-smoking-shunning-sunbeds-and-spotting-the-signs/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2012/03/22/podcast-cancer-genes-kids-smoking-shunning-sunbeds-and-spotting-the-signs/</guid>
				<pubDate>Thu, 22 Mar 2012 13:31:55 GMT</pubDate>
				<author>Kat Arney</author>
				<description><![CDATA[In this month’s podcast a landmark cancer study sheds light on tumour genes, and experts suggest that more breast cancer patients should have genetic tests. New figures reveal worrying numbers of schoolchildren taking up smoking, and leading model agencies sign up &#8230; <a href="http://scienceblog.cancerresearchuk.org/2012/03/22/podcast-cancer-genes-kids-smoking-shunning-sunbeds-and-spotting-the-signs/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				<enclosure url="http://scienceblog.cancerresearchuk.org/wp-content/uploads/2012/03/063_cancer_research_uk_podcast_march_2012.mp3" length="14405717" type="audio/mpeg"/>
			</item>
			<item>
				<title>News digest – complex kidney tumours, smoking warning, HRT and more</title>
				<link>http://scienceblog.cancerresearchuk.org/2012/03/10/news-digest-complex-kidney-tumours-smoking-warning-hrt-and-more/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2012/03/10/news-digest-complex-kidney-tumours-smoking-warning-hrt-and-more/</guid>
				<pubDate>Sat, 10 Mar 2012 09:00:46 GMT</pubDate>
				<author>Oliver Childs</author>
				<description><![CDATA[Some weeks are busier than others, and the past seven days have been a whirlwind. Lots of fascinating cancer research has been covered in the media, including some important work by our own scientists. We&#8217;ve summarised the week for you &#8230; <a href="http://scienceblog.cancerresearchuk.org/2012/03/10/news-digest-complex-kidney-tumours-smoking-warning-hrt-and-more/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				
			</item>
			<item>
				<title>On the origin of tumours</title>
				<link>http://scienceblog.cancerresearchuk.org/2012/03/07/on-the-origin-of-tumours/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2012/03/07/on-the-origin-of-tumours/</guid>
				<pubDate>Wed, 07 Mar 2012 22:00:21 GMT</pubDate>
				<author>Henry Scowcroft</author>
				<description><![CDATA[&#8220;Cancer starts when a single cell in our body starts dividing out of control.&#8221; We repeat this statement so often it would be banal, were it not for its implications. But after a single, initial, malignant cell division, what happens &#8230; <a href="http://scienceblog.cancerresearchuk.org/2012/03/07/on-the-origin-of-tumours/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				
			</item>
			<item>
				<title>Shutting down cells’ ‘back-up generator’ to beat kidney cancer</title>
				<link>http://scienceblog.cancerresearchuk.org/2011/08/17/destroying-cells-back-up-generator-to-beat-kidney-cancer/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2011/08/17/destroying-cells-back-up-generator-to-beat-kidney-cancer/</guid>
				<pubDate>Wed, 17 Aug 2011 18:17:48 GMT</pubDate>
				<author>Henry Scowcroft</author>
				<description><![CDATA[As well as the ingenuity, dedication and skill of their staff, modern hospitals can’t function properly without a reliable electricity supply. This is so critical that hospitals have a back-up generator to keep their life-saving systems working in an emergency.. &#8230; <a href="http://scienceblog.cancerresearchuk.org/2011/08/17/destroying-cells-back-up-generator-to-beat-kidney-cancer/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				
			</item>
			<item>
				<title>Kidney cancer drug access – the end of the story?</title>
				<link>http://scienceblog.cancerresearchuk.org/2009/08/27/kidney-cancer-drug-access-the-end-of-the-story/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2009/08/27/kidney-cancer-drug-access-the-end-of-the-story/</guid>
				<pubDate>Thu, 27 Aug 2009 18:06:54 GMT</pubDate>
				<author>Jon Spiers</author>
				<description><![CDATA[In April we wrote about the decision by the National Institute of Health and Clinical Excellence (NICE) not to recommend three new treatments for advanced kidney cancer on the NHS. Today NICE have announced their final decision on these drugs. As &#8230; <a href="http://scienceblog.cancerresearchuk.org/2009/08/27/kidney-cancer-drug-access-the-end-of-the-story/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				
			</item>
			<item>
				<title>NICE says no to three drugs for advanced kidney cancer</title>
				<link>http://scienceblog.cancerresearchuk.org/2009/04/29/nice-says-no-to-three-drugs-for-advanced-kidney-cancer/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2009/04/29/nice-says-no-to-three-drugs-for-advanced-kidney-cancer/</guid>
				<pubDate>Wed, 29 Apr 2009 17:53:07 GMT</pubDate>
				<author>Henry Scowcroft</author>
				<description><![CDATA[The National Institute of Health and Clinical Excellence (NICE) has announced its final decision on whether people with advanced kidney cancer can have access to three controversial new drugs &#8211; bevicisumab (Avastin), sorafenib (Nexavar) and temsirolimus (Torisel). Unlike sunitinib (Sutent), &#8230; <a href="http://scienceblog.cancerresearchuk.org/2009/04/29/nice-says-no-to-three-drugs-for-advanced-kidney-cancer/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				
			</item>
			<item>
				<title>NICE recommends Sutent (sunitinib) for advanced kidney cancer</title>
				<link>http://scienceblog.cancerresearchuk.org/2009/02/04/nice-recommends-sutent-sunitinib-for-advanced-kidney-cancer/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2009/02/04/nice-recommends-sutent-sunitinib-for-advanced-kidney-cancer/</guid>
				<pubDate>Wed, 04 Feb 2009 16:50:18 GMT</pubDate>
				<author>Henry Scowcroft</author>
				<description><![CDATA[Six months after their preliminary decision, the National Institute of Health and Clinical Excellence (NICE) today issued its final guidance on the chemotherapy drug Sutent (sunitinib). The drug will now be available on the NHS to treat patients with advanced &#8230; <a href="http://scienceblog.cancerresearchuk.org/2009/02/04/nice-recommends-sutent-sunitinib-for-advanced-kidney-cancer/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				
			</item>
			<item>
				<title>NICE meets to decide about kidney cancer drugs – we were there</title>
				<link>http://scienceblog.cancerresearchuk.org/2009/01/20/nice-meets-to-decide-about-kidney-cancer-drugs-we-were-there/</link>
				<guid>http://scienceblog.cancerresearchuk.org/2009/01/20/nice-meets-to-decide-about-kidney-cancer-drugs-we-were-there/</guid>
				<pubDate>Tue, 20 Jan 2009 09:43:08 GMT</pubDate>
				<author>Emma Gilgunn-Jones</author>
				<description><![CDATA[35 experts, 7 administrators, 15 public observers&#8230; one very important decision. Last week, the National Institute of Health and Clinical Excellence (NICE) held a meeting in Manchester to finally decide whether or not to recommend four drugs for advanced kidney &#8230; <a href="http://scienceblog.cancerresearchuk.org/2009/01/20/nice-meets-to-decide-about-kidney-cancer-drugs-we-were-there/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
				
			</item>
		</channel>
</rss